je.st
news
Tag: patients
Art Program Offers Patients A Chance To Just Be Kids
2014-02-23 13:48:15| Chemicals - Topix.net
Beth Carlough is the Child Life Manager of the Nemours/Alfred I. duPont Hospital for Children in Wilmington.
West Virginia doctors advising some patients not drink tap water
2014-02-06 00:30:00| Climate Ark Climate Change & Global Warming Newsfeed
Associated Press: A county health official in West Virginia said doctors are advising some patients not to drink tap water weeks after it was deemed safe from a chemical contamination, though a federal health official on Wednesday said it could be used for any purpose. The January 9 spill at Freedom Industries in Charleston spurred a water-use ban for 300,000 people. After officials cleared thousands of people to use water again, Centers for Disease Control and Prevention officials advised pregnant women to consider...
Tags: west
water
virginia
drink
Furiex Pharmaceuticals Announces Positive Top-Line Results Of Two Pivotal Phase III Clinical Trials Of Eluxadoline In Patients With IBS-d
2014-02-05 07:38:22| drugdiscoveryonline Home Page
Furiex Pharmaceuticals, Inc. recently announced top-line results indicating the company’s two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain
Tags: with
results
iii
positive
Legislation Introduced to Communicate Prescription Changes to Patients and Physicians
2014-01-22 06:00:00| Industrial Newsroom - All News for Today
BIO and Washington Biotechnology & Biomedical Association commend Washington State House and Senate for advancing legislation – HB 2326 and SB 6091 – designed to create pathway for substitution of interchangeable biologic medicines. Endorsed by broad coalition of biologic and biosimilar manufacturing companies, legislation represents significant step forward, ensures transparency and communication between patients and their treatment teams, and is consistent with BIO ...This story is related to the following:Trade Associations
Tags: introduced
patients
legislation
communicate
Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma
2014-01-13 14:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Expects to Complete Application in First Half of 2014 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today it has started a rolling submission to the U.S. Food and Drug Administration (FDA) of a Biologics License Application for MK-3475, the companys investigational anti-PD-1 immunotherapy, for patients with advanced melanoma who have been previously treated with ipilimumab. A rolling submission allows completed portions of the application to be submitted and reviewed by the FDA on an ongoing basis. Language: English Contact: MerckMedia:Ian McConnell, 908-423-3046Claire Mulhearn, 908-423-7425orInvestors:Carol Ferguson, 908-500-1101Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
advanced
application
license
Sites : [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] next »